{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:02:55Z","timestamp":1793404975265,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"French \u00abMinist\u00e8re de la Recherche et de la Technologie\u00bb"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.biochi.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T05:01:15Z","timestamp":1370840475000},"page":"1811-1827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":531,"title":["Potential role and therapeutic interests of myo-inositol in metabolic diseases"],"prefix":"10.1016","volume":"95","author":[{"given":"Marine L.","family":"Croze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe O.","family":"Soulage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2013.05.011_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.123.3202.845-a","article-title":"myo-Inositol as an essential growth factor for normal and malignant human cells in tissue culture","volume":"123","author":"Eagle","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.biochi.2013.05.011_bib2","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1096\/fj.05-4192fje","article-title":"Sodium\/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves","volume":"19","author":"Chau","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.biochi.2013.05.011_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/jbmr.240","article-title":"Sodium\/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation","volume":"26","author":"Dai","year":"2011","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.biochi.2013.05.011_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejogrb.2011.07.038","article-title":"Contribution of myo-inositol and melatonin to human reproduction","volume":"159","author":"Carlomagno","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.biochi.2013.05.011_bib5","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.urology.2012.03.005","article-title":"Myoinositol: does it improve sperm mitochondrial function and sperm motility?","volume":"79","author":"Condorelli","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.biochi.2013.05.011_bib6","first-page":"509","article-title":"Effects of myo-inositol supplementation on oocyte\u2019s quality in PCOS patients: a double blind trial","volume":"15","author":"Ciotta","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib7","first-page":"452","article-title":"myo-Inositol rather than d-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles A prospective, controlled, randomized trial","volume":"15","author":"Unfer","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib8","first-page":"129","article-title":"Effects of myoinositol on sperm mitochondrial function in-vitro","volume":"15","author":"Condorelli","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1301\/00296640260042748","article-title":"Involvement of inositol in reproduction","volume":"60","author":"Beemster","year":"2002","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.biochi.2013.05.011_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/endo.132.2.8425484","article-title":"Chiroinositol deficiency and insulin resistance II acute effects of d-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and\u00a0spontaneously insulin-resistant rhesus monkeys","volume":"132","author":"Ortmeyer","year":"1993","journal-title":"Endocrinology"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.biochi.2013.05.011_bib11","doi-asserted-by":"crossref","first-page":"605S","DOI":"10.1002\/j.1550-8528.1995.tb00232.x","article-title":"Effects of d-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys","volume":"3","author":"Ortmeyer","year":"1995","journal-title":"Obes. Res."},{"key":"10.1016\/j.biochi.2013.05.011_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/j.1550-8528.1996.tb00271.x","article-title":"Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys","volume":"4","author":"Ortmeyer","year":"1996","journal-title":"Obes. Res."},{"key":"10.1016\/j.biochi.2013.05.011_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/09513590.2011.650660","article-title":"Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials","volume":"28","author":"Unfer","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biochi.2013.05.011_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.nu.06.070186.003023","article-title":"Metabolism and function of myo-inositol and inositol phospholipids","volume":"6","author":"Holub","year":"1986","journal-title":"Annu. Rev. Nutr."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.biochi.2013.05.011_bib15","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1002\/mnfr.200900099","article-title":"Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis","volume":"53","author":"Schlemmer","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biochi.2013.05.011_bib16","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/ajcn\/33.9.1954","article-title":"myo-Inositol content of common foods: development of a high-myo-inositol diet","volume":"33","author":"Clements","year":"1980","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biochi.2013.05.011_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/bj1560375","article-title":"Studies on the metabolic role of myo-inositol distribution of radioactive myo-inositol in the male rat","volume":"156","author":"Lewin","year":"1976","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2013.05.011_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1042\/BST0371099","article-title":"Cellular consequences of inositol depletion","volume":"37","author":"Deranieh","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biochi.2013.05.011_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2012.04.010","article-title":"Contributions in astrocytes of SMIT1\/2 and HMIT to myo-inositol uptake at different concentrations and pH","volume":"61","author":"Fu","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biochi.2013.05.011_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI109728","article-title":"Concentration of myo-inositol in skeletal muscle of the rat occurs without active transport","volume":"65","author":"Molitoris","year":"1980","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biochi.2013.05.011_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.abb.2008.11.008","article-title":"Human sodium\/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells","volume":"481","author":"Lin","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biochi.2013.05.011_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0006-291X(63)90416-9","article-title":"Biosynthesis of inositol in rat testis homogenate","volume":"12","author":"Eisenberg","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2013.05.011_bib23","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1016\/S0021-9258(18)48650-4","article-title":"The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices","volume":"238","author":"Hauser","year":"1963","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib24","doi-asserted-by":"crossref","first-page":"e7364","DOI":"10.1371\/journal.pone.0007364","article-title":"Crosstalks between myo-inositol metabolism, programmed cell death and basal immunity in Arabidopsis","volume":"4","author":"Meng","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2013.05.011_bib25","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1016\/S0021-9258(18)41870-4","article-title":"In\u00a0vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues","volume":"267","author":"Pak","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0006-291X(77)80202-7","article-title":"Interconversion of myo- and scyllo-inositol with simultaneous formation of neo-inositol by an NADP+ dependent epimerase from bovine brain","volume":"77","author":"Hipps","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2013.05.011_bib27","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1016\/S0021-9258(19)63366-1","article-title":"CDP-diglyceride:inositol transferase from rat liver purification and properties","volume":"252","author":"Takenawa","year":"1977","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.1969.tb06850.x","article-title":"Distribution and properties of CDP-diglyceride:inositol transferase from brain","volume":"16","author":"Benjamins","year":"1969","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2013.05.011_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0003-9861(67)90357-8","article-title":"Metabolism of myo-inositol in animals II complete catabolism of myo-inositol-14C by rat kidney slices","volume":"118","author":"Howard","year":"1967","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biochi.2013.05.011_bib30","series-title":"Inositol Material Safety Data Sheet MSDS Number 12480","year":"1996"},{"key":"10.1016\/j.biochi.2013.05.011_bib31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1055-9965.EPI-06-0128","article-title":"A\u00a0phase I study of myo-inositol for lung cancer chemoprevention","volume":"15","author":"Lam","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.biochi.2013.05.011_bib32","first-page":"931","article-title":"Inositol safety: clinical evidences","volume":"15","author":"Carlomagno","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2337\/diab.36.3.396","article-title":"Banting lecture 1986 does a common mechanism induce the diverse complications of diabetes?","volume":"36","author":"Winegrad","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.biochi.2013.05.011_bib34","series-title":"Mechanisms Underlying the Abnormal Inositol Metabolisms in Diabetes Mellitus","author":"Chang","year":"2011"},{"key":"10.1016\/j.biochi.2013.05.011_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199008093230603","article-title":"Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus","volume":"323","author":"Kennington","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2013.05.011_bib36","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0006-291X(02)00313-3","article-title":"Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls","volume":"293","author":"Sun","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2013.05.011_bib37","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1073\/pnas.90.13.5924","article-title":"chiro-Inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects","volume":"90","author":"Asplin","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2013.05.011_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI110688","article-title":"Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve competitive inhibition by glucose and lack of an insulin effect","volume":"70","author":"Greene","year":"1982","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biochi.2013.05.011_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0026-0495(89)90174-1","article-title":"The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells","volume":"38","author":"Yorek","year":"1989","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.biochi.2013.05.011_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0167-4889(90)90056-J","article-title":"Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells","volume":"1052","author":"Olgem\u00f6ller","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2013.05.011_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0026-0495(90)90145-3","article-title":"Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells","volume":"39","author":"Haneda","year":"1990","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.biochi.2013.05.011_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/02713689209069164","article-title":"myo-Inositol transport in the lens of galactose-maintained rats","volume":"11","author":"Beyer-Mears","year":"1992","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biochi.2013.05.011_bib43","first-page":"2334","article-title":"Study of the polyol pathway and cell permeability changes in human lens and retinal pigment epithelium in tissue culture","volume":"33","author":"Reddy","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bj1790549","article-title":"Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes","volume":"179","author":"Whiting","year":"1979","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2013.05.011_bib45","doi-asserted-by":"crossref","first-page":"17952","DOI":"10.1073\/pnas.0509089102","article-title":"Modulation of renal-specific oxidoreductase\/myo-inositol oxygenase by high-glucose ambience","volume":"102","author":"Nayak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2013.05.011_bib46","first-page":"1996","article-title":"Dracorhodin perchlorate inhibit high glucose induce serum and glucocorticoid induced protein kinase 1 and fibronectin expression in human mesangial cells","volume":"35","author":"Xie","year":"2010","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.biochi.2013.05.011_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/diab.29.3.227","article-title":"Abnormal sciatic nerve myo-inositol metabolism in the streptozotocin-diabetic rat: effect of insulin treatment","volume":"29","author":"Clements","year":"1980","journal-title":"Diabetes"},{"key":"10.1016\/j.biochi.2013.05.011_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diab.46.2.301","article-title":"Supplemental myo-inositol prevents l-fucose-induced diabetic neuropathy","volume":"46","author":"Sima","year":"1997","journal-title":"Diabetes"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.biochi.2013.05.011_bib49","doi-asserted-by":"crossref","first-page":"B74","DOI":"10.1007\/BF03168192","article-title":"Diabetic neuropathies","volume":"40","author":"Sima","year":"1997","journal-title":"Diabetologia"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.biochi.2013.05.011_bib50","first-page":"ii15","article-title":"The diabetic neuropathies: types, diagnosis and management","volume":"74","author":"Llewelyn","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.biochi.2013.05.011_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0021-9258(19)40196-8","article-title":"Inhibition of Na, K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid","volume":"265","author":"Oishi","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/0705-MR-134","article-title":"Diabetic nephropathy: mechanisms of renal disease progression","volume":"233","author":"Kanwar","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biochi.2013.05.011_bib53","first-page":"197","article-title":"Molecular Mechanism of Insulin Resistance in Spontaneous Diabetic GK (Goto-Kakizaki) Rats","author":"Suzuki","year":"1991"},{"key":"10.1016\/j.biochi.2013.05.011_bib54","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/bj0180891","article-title":"Studies on inositol: the synthesis of inositol in the animal body","volume":"18","author":"Needham","year":"1924","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2013.05.011_bib55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1172\/JCI102979","article-title":"Thr renal excretion of inositol by normal and diabetic rats 1","volume":"33","author":"Daughaday","year":"1954","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biochi.2013.05.011_bib56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1210\/endo.132.2.8425483","article-title":"Chiroinositol deficiency and insulin resistance I urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys","volume":"132","author":"Ortmeyer","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.biochi.2013.05.011_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2337\/diacare.19.1.76","article-title":"Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance","volume":"19","author":"Larner","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2013.05.011_bib58","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1073\/pnas.90.16.7759","article-title":"Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor","volume":"90","author":"Pak","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2013.05.011_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.biochi.2013.05.011_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer","year":"2010","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.biochi.2013.05.011_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513590903366996","article-title":"Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women","volume":"26","author":"Raffone","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biochi.2013.05.011_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09513590801893232","article-title":"myo-Inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome","volume":"24","author":"Genazzani","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biochi.2013.05.011_bib63","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09513590701672405","article-title":"myo-Inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction","volume":"23","author":"Papaleo","year":"2007","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biochi.2013.05.011_bib64","first-page":"347","article-title":"Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS","volume":"11","author":"Gerli","year":"2007","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib65","first-page":"151","article-title":"Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial","volume":"7","author":"Gerli","year":"2003","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib66","first-page":"1","article-title":"Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome A randomized study","author":"Artini","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biochi.2013.05.011_bib67","first-page":"105","article-title":"Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial","volume":"13","author":"Costantino","year":"2009","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2013.05.011_bib68","first-page":"239","article-title":"Assessment of the modification of the clinical, endocrinal and metabolical profile of patients with PCOS syndrome treated with myo-inositol","volume":"64","author":"Venturella","year":"2012","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.biochi.2013.05.011_bib69","doi-asserted-by":"crossref","DOI":"10.3109\/14767058.2013.766691","article-title":"Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial","author":"Matarrelli","year":"2013","journal-title":"J.\u00a0Matern. Fetal Neonatal. Med."},{"key":"10.1016\/j.biochi.2013.05.011_bib70","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-1371","article-title":"myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study","author":"D'Anna","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2013.05.011_bib71","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/13697137.2011.631063","article-title":"One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome","volume":"15","author":"Santamaria","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.biochi.2013.05.011_bib72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/gme.0b013e3181e8e1b1","article-title":"Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study","volume":"18","author":"Giordano","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.biochi.2013.05.011_bib73","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1464-5491.2011.03284.x","article-title":"The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes","volume":"28","author":"Corrado","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biochi.2013.05.011_bib74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1463-1326.2008.00965.x","article-title":"Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome","volume":"11","author":"Gupta","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biochi.2013.05.011_bib75","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2337\/dc05-2174","article-title":"Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome","volume":"29","author":"Esposito","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2013.05.011_bib76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabet.2009.03.005","article-title":"Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial","volume":"35","author":"Fontbonne","year":"2009","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.biochi.2013.05.011_bib77","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/sj.bjp.0703523","article-title":"Insulin-like effect of pinitol","volume":"130","author":"Bates","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biochi.2013.05.011_bib78","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/jmf.2006.9.182","article-title":"Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus","volume":"9","author":"Kang","year":"2006","journal-title":"J.\u00a0Med. Food"},{"key":"10.1016\/j.biochi.2013.05.011_bib79","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.ejcn.1602081","article-title":"Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study","volume":"59","author":"Kim","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biochi.2013.05.011_bib80","doi-asserted-by":"crossref","first-page":"E932","DOI":"10.1152\/ajpendo.00479.2011","article-title":"Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and \u03b2-cells","volume":"302","author":"Shen","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2013.05.011_bib81","unstructured":"B.C. Hansen, H.L. Greene, H.K. Ortmeyer, Treatment of diabetes by myo-inositol administration, U.S. Patent 5736392, 1998."},{"key":"10.1016\/j.biochi.2013.05.011_bib82","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI108052","article-title":"Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes","volume":"55","author":"Greene","year":"1975","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biochi.2013.05.011_bib83","article-title":"Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice","author":"Croze","year":"2012","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.biochi.2013.05.011_bib84","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1271\/bbb.90963","article-title":"d-pinitol and myo-inositol stimulate translocation of glucose transporter 4 in skeletal muscle of C57BL\/6 mice","volume":"74","author":"Dang","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"Pt 2","key":"10.1016\/j.biochi.2013.05.011_bib85","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1101\/SQB.1988.053.01.111","article-title":"Insulin mediators: structure and formation","volume":"53","author":"Larner","year":"1988","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.biochi.2013.05.011_bib86","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1210\/endo.132.2.8425485","article-title":"Chiroinositol deficiency and insulin resistance III acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in\u00a0vivo","volume":"132","author":"Huang","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.biochi.2013.05.011_bib87","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1073\/pnas.83.16.5793","article-title":"Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid","volume":"83","author":"Saltiel","year":"1986","journal-title":"PNAS"},{"key":"10.1016\/j.biochi.2013.05.011_bib88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF03401978","article-title":"Diabetes and the role of inositol-containing lipids in insulin signaling","volume":"5","author":"Jones","year":"1999","journal-title":"Mol. Med."},{"key":"10.1016\/j.biochi.2013.05.011_bib89","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2119\/molmed.2010.00107","article-title":"d-chiro-Inositol glycans in insulin signaling and insulin resistance","volume":"16","author":"Larner","year":"2010","journal-title":"Mol. Med."},{"key":"10.1016\/j.biochi.2013.05.011_bib90","first-page":"909","article-title":"Mannose, glucosamine and inositol monophosphate inhibit the effects of insulin on lipogenesis further evidence for a role for inositol phosphate-oligosaccharides in insulin action","volume":"266","author":"Machicao","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2013.05.011_bib91","doi-asserted-by":"crossref","first-page":"15285","DOI":"10.1016\/S0021-9258(18)48172-0","article-title":"A\u00a0phospho-oligosaccharide mimics the effect of insulin to inhibit isoproterenol-dependent phosphorylation of phospholipid methyltransferase in isolated adipocytes","volume":"262","author":"Kelly","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib92","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1073\/pnas.91.23.11040","article-title":"Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats","volume":"91","author":"Farese","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2013.05.011_bib93","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1021\/jm030071j","article-title":"Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity","volume":"46","author":"Larner","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib94","first-page":"217","article-title":"Identification of a novel inositol glycan signaling pathway with significant therapeutic relevance to insulin resistance: an insulin signaling model using both tyrosine kinase and G-proteins","volume":"7","author":"Larner","year":"1999","journal-title":"Diabetes Rev."},{"key":"10.1016\/j.biochi.2013.05.011_bib95","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1073\/pnas.87.4.1476","article-title":"Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells","volume":"87","author":"Romero","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2013.05.011_bib96","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1210\/endo.132.4.8462454","article-title":"The involvement of inositol phosphoglycan mediators in the modulation of steroidogenesis by insulin and insulin-like growth factor-I","volume":"132","author":"Romero","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.biochi.2013.05.011_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1432-1033.1990.tb15392.x","article-title":"Asymmetric distribution of the phosphatidylinositol-linked phospho-oligosaccharide that mimics insulin action in the plasma membrane","volume":"188","author":"Varela","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biochi.2013.05.011_bib98","doi-asserted-by":"crossref","DOI":"10.1021\/cb1002152","article-title":"Synthetic inositol phosphoglycans related to GPI lack insulin-mimetic activity","author":"Hecht","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biochi.2013.05.011_bib99","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1016\/S0040-4039(00)61497-1","article-title":"Insulin second messengers: synthesis of 6-O-(2-amino-2-deoxy-\u03b1-d-glucopyranosyl)-d-chiro-inositol-1-phosphate","volume":"34","author":"Reddy","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biochi.2013.05.011_bib100","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/jo00035a015","article-title":"Synthesis and characterization of an insulin-mimetic disaccharide","volume":"57","author":"Plourde","year":"1992","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.biochi.2013.05.011_bib101","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1021\/bi9806201","article-title":"Structure\u2013activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action","volume":"37","author":"Frick","year":"1998","journal-title":"Biochemistry"},{"issue":"Pt 1","key":"10.1016\/j.biochi.2013.05.011_bib102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj3360163","article-title":"Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes","volume":"336","author":"Frick","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2013.05.011_bib103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10616-007-9107-y","article-title":"Rat L6 myotubes as an in\u00a0vitro model system to study GLUT4-dependent glucose uptake stimulated by inositol derivatives","volume":"55","author":"Yap","year":"2007","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biochi.2013.05.011_bib104","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0140-6736(78)92043-3","article-title":"Effect of myo-inositol on peripheral-nerve function in diabetes","volume":"2","author":"Salway","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2013.05.011_bib105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.41.4.333","article-title":"Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats","volume":"41","author":"Jefferys","year":"1978","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.biochi.2013.05.011_bib106","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00282524","article-title":"Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats","volume":"25","author":"Mayer","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.biochi.2013.05.011_bib107","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1681\/ASN.V1111220","article-title":"Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose","volume":"1","author":"Ziyadeh","year":"1991","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.biochi.2013.05.011_bib108","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/0026-0495(90)90161-5","article-title":"Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes","volume":"39","author":"Cohen","year":"1990","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.biochi.2013.05.011_bib109","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF00400577","article-title":"Effect of myo-inositol supplementation on the development of renal pathological changes in the Cohen diabetic (type 2) rat","volume":"38","author":"Cohen","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.biochi.2013.05.011_bib110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000138572","article-title":"Dietary myo-inositol effect on sugar cataractogenesis","volume":"39","author":"Beyer-Mears","year":"1989","journal-title":"Pharmacology"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908413001582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908413001582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T11:59:15Z","timestamp":1645703955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908413001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":110,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0300908413001582"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2013.05.011","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2013.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}